ArticleScientific reports2025
Recalled childhood trauma and post-psychedelic trajectories of change in a mixed-methods study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Evaluating the evidence for repressed memory recovery in psychedelic contexts.Psychopharmacology · 2026Review
- Rebuttal to "Questioning the recovery of dissociated traumatic memories under psilocybin".Journal of eating disorders · 2026Article
- Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences.The International journal on drug policy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This mixed-methods study examines how participant-identified childhood or youth trauma resurfaces during psychedelic states and how such episodes relate to post-experience trajectories. Including events participants identified as traumatic during psychedelic experiences, and subsequent psychological outcomes, both positive and negative. While psychedelics can facilitate emotional processing of autobiographical material, a minority experience adverse effects or re-traumatization when trauma resurfaces. Phase 1 surveyed 608 individuals who experienced post-psychedelic difficulties lasting beyond acute effects. Those who reported that their post-psychedelic difficulties seemed to be related to early trauma (41.8%) were significantly older, more often female, were more likely to report a prior mental-illness diagnosis, and were more likely to use psychedelics in guided settings compared to those who did not. They also reported significantly more emotional difficulties but fewer perceptual difficulties after the experience. Phase 2 involved semi-structured interviews with 18 purposively selected participants. Reflexive thematic analysis identified four themes describing how trauma surfaced during psychedelic experiences: direct trauma re-experiencing (39% of participants, including some with no prior memory of events), symbolic/somatic re-embodiment (22%), and fragmentation and confusion (50%). A fourth theme captured varied post-experience trajectories, ranging from predominantly positive integration (50%) to mixed effects (28%) to re-traumatization (22%). The study highlights uncertainty around memory veridicality as a source of ongoing distress for some participants. Findings emphasize the critical need for trauma-informed approaches to psychedelic use, stressing appropriate preparation, supportive settings, and robust integration support to maximize therapeutic potential while preventing re-traumatization.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.